Static Content

Drug Watch International networks with organizations that have goals consistent with our mission statement. However, as a matter of policy, Drug Watch International does not officially endorse other organizations and/or individuals. Drug Watch International is not responsible for the contents of any website other than its own (www.drugwatch.org), nor does it endorse any product or service provided by any other organization.










BOARD OF DIRECTORS

John J. Coleman, Ph. D., Virginia, President

Mina Seinfeld de Carakushansky, Brazil

Ed Moses, Missouri, Vice President, Secretary

Susie Dugan, Nebraska, Treasurer

Terrence P. Farley, Esq., New Jersey

Jeanette McDougal, Arkansas, Hemp Committee Chairman

Margaret L. Petito, Washington, DC

Alex J. Romero, Arizona

Wayne Roques, Florida

Geraldine Silverman, New Jersey

Monte Stiles, Idaho

Joan Bellm, Founder and Honorary Director, Illinois

 

COUNCIL OF ADVISORS

Pat Barton, Florida
Daniel Bent, Esq., Hawaii
James M. Ch'ien, M.D., Hong Kong
Dr. Kachit Choopanya, Thailand
C. E. Edwards, Arizona
Chief Ruben Greenberg, South Carolina
Datuk Haji Idris Ibrahim, Dmsm Jsm, Malaysia
Jerry Johansen, Texas
Cliff Kincaid, Maryland
Lt. Col. (USA Ret.) Robert Maginnis, Washington, DC
Fred J. Payne, MD, Louisiana
Bill Oliver, Georgia
Maggie Petito, Washington, D.C.
David Risley, Esq., Illinois
Arlene Seal, Ph.D., Pennsylvania
Padma Talcherkar, M.D., FAAP, Illinois

Drug Watch International is a volunteer, non-profit, drug information network and advocacy organization that promotes the creation of drug-free healthy cultures in the world and opposes the legalization of drugs.  The organization upholds a comprehensive approach to drug issues, involving prevention, education, research, intervention, treatment, law enforcement, and interdiction.

The purpose of Drug Watch is to provide the public, policy makers, and the media with current information, factual research, and expert resources; and to counter drug-advocacy propaganda.  An active, highly informed Board of Directors governs Drug Watch International and coordinates a network of delegates from across the United States and over 25 nations, a Liaison Network of representatives from international, national, and state prevention and treatment organizations, a Board of Advisors, and the prestigious International Drug Strategy Institute.

The International Drug Strategy Institute, a division of Drug Watch International, is a bipartisan group of physicians, attorneys, educators, law enforcement officials, and drug prevention specialists who provide expertise on national and international drug research.  The Institute pursues research and public policy on drug issues consistent with the comprehensive approach established by Drug Watch International.

Drug Watch International was founded September 14, 1991, in Chicago, Illinois.

Present were:

Joan Bellm … Carlinville, Illinois (Founder)

Rosanna Creighton … Portland, Oregon (Public Policy Expert)

Otto Moulton … Danvers, Massachusetts (Drug Culture Expert)

David Noffs … Chicago, Illinois (International Prevention Foundation)

Bob Peterson … Lansing, Michigan (Attorney)

David Noffs was elected the first President of Drug Watch International.

The International Drug Strategy Institute was formed February 13, 1993, in St. Louis, Missouri.  Eric Voth, MD, FACP, was appointed the Director. The Institute pursues research and public policy on drug issues consistent with the comprehensive approach established by Drug Watch International.

Drug Watch International is a volunteer non-profit drug information network and organization that promotes the creation of healthy drug-free cultures in the world and opposes the legalization of drugs prohibited by national and international laws.  The organization upholds a comprehensive approach to drug issues involving prevention, education, intervention/treatment, and law enforcement/interdiction. 
Drug Watch International is comprised of a Board of Directors, state and international Delegates, a Liaison Network of representatives from international, national, and state prevention and treatment organizations, Council of Advisors, and the International Drug Strategy Institute. 

The purpose of Drug Watch International is to provide policymakers, the media, and the public with current information, factual research, expert resources, and to counter drug advocacy propaganda.



Drug Watch Says Goodbye to an Old Friend
Otto Moulton's Courage Never Failed nor Faltered
Click here to read the article



News Notes
Almost 10% of first-year college students at a mid-Atlantic university have a cannabis use disorder, and 38.4% of those who used marijuana five or more times in the past year reported potentially serious cannabis-related problems.
("Addictive Behaviors" 33(3):397-411, March 2008: CESAR Fax 1/21/2008)


On March 17, 1999, the Institute of Medicine (IOM) released its report, "Marijuana and Medicine: Assessing the Science Base." At a news conference on that date, Principal Investigators John A. Benson and Stanley J. Watson Jr., commented:
(Benson) "It is important to stress that the goal of these trials should not be to develop marijuana as a licensed drug. Rather, these trials should be done in parallel with the development of new, safe delivery systems of drugs related to the compounds found in marijuana."

(Watson) "Marijuana's future as medicine does not involve smoking. It involves exploiting the potential in cannabinoids such as THC, the key psychoactive ingredient of marijuana."

Click here for Institute of Medicine Report Recommendations.

Click here for the Statement from the FDA

INDIRECT LINKS - a caution

Before we add a website to our collection of links, we make every effort to ensure the website has similar philosophies, acceptable content, and commitment to accuracy ? as does Drug Watch International.  But these websites may in turn link onward to other websites, and some of these indirect links may not be in agreement with our position or philosophy.  Please, therefore, do not assume that any website to which we are linked, particularly indirectly, is automatically recommended by Drug Watch International.

 

 


Prevention Groups | Agencies | Resources | Other


Prevention Groups

 


Prevention Groups | Agencies | Resources | Other


Agencies

 


Prevention Groups | Agencies | Resources | Other


Resources

 


Prevention Groups | Agencies | Resources | Other


Other